1 ML methylergonovine maleate 0.2 MG/ML Injection — RxCUI 996828
RxNorm drug concept · Semantic clinical drug
RxCUI 996828
Semantic clinical drug · SCD
● Current RxNorm concept 7 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI996828
Official name1 ML methylergonovine maleate 0.2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylergonovine maleate 0.2 MG per 1 ML Injection; methylergonovine maleate 0.2 MG in 1 ML Injection
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)1,627 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methylergonovine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a medication given right after childbirth to help your uterus contract firmly and stop or prevent heavy bleeding. Sometimes the uterus doesn't tighten up on its own the way it...
- What exactly is methylergonovine used for?
- You'll typically take the tablet three or four times a day for up to one week after delivery, as your provider directs. One thing worth knowing: if you're taking it continuously in...
- How should I take the tablet form, and is there anything I should know about timing?
🕸️ Concept Web — How 1 ML methylergonovine maleate 0.2 MG/ML Injectio... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
1 ML methylergonovine maleate 0.2 MG/ML Injection
RxCUI 996828 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Methylergonovine
6883IN -
Methylergonovine maleate
84158PIN
-
Methylergonovine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methylergonovine Injection
1740921SCDF -
Methylergonovine maleate Injection
2647708SCDFP -
Methylergonovine Injectable Product
1162885SCDG -
Methylergonovine maleate Injectable Product
2660085SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Methylergonovine Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methylergonovine maleate 0.2 MG/ML
996827SCDC
-
Methylergonovine maleate 0.2 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methylergonovine maleate 0.2 MG/ML
SCDC · 996827 -
Methylergonovine Injection
SCDF · 1740921 -
Methylergonovine maleate Injection
SCDFP · 2647708 -
Methylergonovine Injectable Product
SCDG · 1162885 -
Methylergonovine maleate Injectable Product
SCDGP · 2660085
📦 FDA Products & Package NDCs
7 products · 7 package NDCs
7 package NDCs map to RxCUI 996828 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00517-0740-20 | 20 VIAL, SINGLE-DOSE in 1 CARTON (0517-0740-20) / 1 mL in 1... | Methylergonovine Maleate | American Regent, Inc. | 2010-06-21 |
| 51662-1556-02 | 1 AMPULE in 1 POUCH (51662-1556-2) / 1 mL in 1 AMPULE (5166... | METHYLERGONOVINE MALEATE | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-14 |
| 51662-1668-01 | 1 mL in 1 VIAL (51662-1668-1) | METHYLERGONOVINE MALEATE | HF Acquisition Co. LLC. DBA HealthFirst | 2010-06-21 |
| 51991-0144-17 | 10 AMPULE in 1 BOX (51991-144-17) / 1 mL in 1 AMPULE | METHYLERGONOVINE MALEATE | Breckenridge Pharmaceutical, Inc. | 2016-11-07 |
| 63629-2074-01 | 10 AMPULE in 1 BOX (63629-2074-1) / 1 mL in 1 AMPULE | METHYLERGONOVINE MALEATE | Bryant Ranch Prepack | 2016-11-07 |
| 63704-0004-01 | 10 AMPULE in 1 BOX (63704-004-01) / 1 mL in 1 AMPULE | METHYLERGONOVINE MALEATE | Pharmacist Pharmaceutical, LLC | 2010-11-01 |
| 72162-1592-02 | 10 AMPULE in 1 BOX (72162-1592-2) / 1 mL in 1 AMPULE | METHYLERGONOVINE MALEATE | Bryant Ranch Prepack | 2016-11-07 |
Observed labelers:
Bryant Ranch Prepack (2) ·
American Regent, Inc. (1) ·
Breckenridge Pharmaceutical, Inc. (1) ·
HF Acquisition Co LLC, DBA HealthFirst (1) ·
HF Acquisition Co. LLC. DBA HealthFirst (1) ·
Pharmacist Pharmaceutical, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2210 | Methylergonovin maleate inj | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.